首页> 外文期刊>Physics in medicine and biology. >Treatment planning considerations in contrast-enhanced radiotherapy: energy and beam aperture optimization.
【24h】

Treatment planning considerations in contrast-enhanced radiotherapy: energy and beam aperture optimization.

机译:对比增强放疗中的治疗计划考虑因素:能量和射束孔径优化。

获取原文
获取原文并翻译 | 示例
           

摘要

It has been shown that the use of kilovoltage x-rays in conjunction with a contrast agent incorporated into the tumor can lead to acceptable treatment plans with regard to the absorbed dose distribution produced in the target as well as in the tissue and organs at risk surrounding it. In this work, several key aspects related to the technology and irradiation techniques necessary to clinically implement this treatment modality are addressed by means of Monte Carlo simulation. The Zubal phantom was used to model a prostate radiotherapy treatment, a challenging site due to the depth of the prostate and the presence of bony structures that must be traversed by the x-ray beam on its way to the target. It is assumed that the concentration levels of the enhancing agent present in the tumor are at or below 10 mg per 1 g of tissue. The Monte Carlo code PENELOPE was used to model a commercial x-ray tube having a tungsten target. X-ray energy spectra for several combinations of peak electron energy and added filtration were obtained. For each energy spectrum, a treatment plan was calculated, with the PENELOPE Monte Carlo code, by modeling the irradiation of the patient as 72 independent conformal beams distributed at intervals of 5 degrees around the phantom in order to model a full x-ray source rotation. The Cimmino optimization algorithm was then used to find the optimum beam weight and energy for different treatment strategies. It is shown that for a target dose prescription of 72 Gy covering the whole tumor, the maximum rectal wall and bladder doses are kept below 52 Gy for the largest concentration of contrast agent of 10 mg per 1 g of tissue. It is also shown that concentrations of as little as 5 mg per 1 g of tissue also render dose distributions with excellent sparing of the organs at risk. A treatment strategy to address the presence of non-uniform distributions of the contrast agent in the target is also modeled and discussed.
机译:已经表明,与在肿瘤中掺入的造影剂一起使用千伏X射线,可以针对靶标以及周围危险组织和器官中产生的吸收剂量分布产生可接受的治疗方案它。在这项工作中,通过蒙特卡罗模拟解决了与临床上实现这种治疗方式所必需的技术和辐照技术有关的几个关键方面。 Zubal体模用于对前列腺放射疗法进行建模,由于前列腺的深度以及X射线束在到达目标的过程中必须横穿的骨骼结构,因此具有挑战性。假定存在于肿瘤中的增强剂的浓度水平为每1g组织等于或低于10mg。使用蒙特卡罗代码PENELOPE对具有钨靶的商业X射线管进行建模。获得了峰值电子能量和附加过滤的几种组合的X射线能谱。对于每个能谱,使用PENELOPE蒙特卡罗代码,通过将患者的辐射建模为围绕幻影以5度为间隔分布的72个独立的共形光束来计算治疗计划,以模拟完整的X射线源旋转。然后,使用Cimmino优化算法找到针对不同治疗策略的最佳射束重量和能量。结果表明,对于覆盖整个肿瘤的72 Gy的目标剂量处方,最大造影剂浓度为每1 g组织10 mg,最大直肠壁和膀胱剂量保持在52 Gy以下。还显示出每1 g组织中低至5 mg的浓度也使剂量分布具有极好的保留处于危险中的器官。还对处理造影剂在目标中存在的不均匀分布的治疗策略进行了建模和讨论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号